How is the Yf-Vax Market Poised for Growth: Trends and Opportunities Through 2034
Enjoy a flat 15% OFF on all 2025 Global Market Reports until March 31st! Use code FY25SAVE to save big—don’t miss out!
What fueled the previous growth in the yf-vax market?
The market size for Yf-Vax has seen significant expansion in the past few years. The value is projected to advance from $6,280 million in 2024 to an estimated $6,780 million by 2025, yielding a compound annual growth rate (CAGR) of 7.8%. The robust increase in the previous period is tied to a surge in global travel to regions affected by yellow fever and heightened awareness on the prevention of the fever. Furthermore, there’s a growing comprehension surrounding the crucial role of immunization in curbing the transmission of yellow fever.
What will be the yf-vax market size in the future?
The market for Yf-Vax is predicted to witness substantial expansion in the coming years. It is projected to reach a value of $9,120 million by 2029, growing at a compound annual growth rate (CAGR) of 7.7%. This projected increase during the forecast period is largely due to the rising demand for vaccines in developing economies, advancements in the means of vaccine distribution, government-initiated immunization campaigns, continuous progress in vaccine distribution infrastructure, and enhancements in vaccine formulation and accessibility. The period under forecast also holds trends such as product clearances, collaborations, and advancements in yellow fever vaccination.
Get your yf-vax market report here!
https://www.thebusinessresearchcompany.com/report/yf-vax-global-market-report-
What main drivers are fueling expansion in the yf-vax market?
The YF-Vax market is predicted to grow due to the rising awareness of vector-borne diseases. These diseases, including malaria, dengue, and Lyme disease, are transmitted through the bites of infected arthropods like mosquitoes, ticks, and fleas. Growing concerns about vector-borne diseases are attributed to climate change, urbanization, increased global travel, and expanding mosquito populations which have resulted in more reported outbreaks. YF-Vax provides valuable protection against yellow fever, a vector-borne disease, by stimulating the immune system to produce antibodies that fight the virus. For example, the World Organization for Animal Health reported that there were 2,422 outbreaks of vector-borne diseases in 28 countries from 2023 to March 2024, including 697 in Europe. Hence, the rising awareness of these diseases is fuelling the YF-Vax market’s growth. Furthermore, the projected growth of the Yf-Vax market is being propelled by an increase in healthcare spending. This rise in spending is linked to an aging population, major advancements in medical technology, a rise in the occurrence of chronic diseases, and increased demand for healthcare services. By providing effective prevention for yellow fever, YF-Vax aids in decreasing healthcare costs by reducing expenses related to severe infection treatments, hospital stays, and the management of outbreaks. For instance, the Office for National Statistics reported that the UK’s healthcare spending grew by 5.6% between 2022 and 2023, reaching roughly $317.63 billion (£292 billion) in 2023, compared to a growth of just 0.9% in 2022. Therefore, the Yf-Vax market’s growth is being driven by increasing healthcare expenditures.
What key areas define the segmentation of the global yf-vax market?
The yf-vaxmarket covered in this report is segmented –
1) By Vaccine Type: Live Attenuated Vaccines; Fractional Dose Vaccine
2) By Transmission Type: Sylvatic Yellow Fever; Intermediate Yellow Fever; Urban Yellow Fever
3) By Distribution Channel: Hospitals; Retail Pharmacies; Government Health Programs
4) By End User: Adult; Geriatric; Pediatric
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19946&type=smp
Who are the dominant players expanding their reach in the yf-vax market?
Major companies operating in the yf-vax market include Sanofi S.A.
How are evolving market trends shaping yf-vax Strategies?
One prevailing trend in the Yf-Vax market is the emphasis on forging strategic partnerships to boost technology integration and extend market penetration. Such partnerships usually involve a cooperative relationship among several entities, pooling their assets, knowledge, and energy to achieve shared goals. As an example, in March 2022, The International Finance Corporation (IFC), an American financial services firm, joined forces with Institut Pasteur de Dakar (IPD), a Senegalese vaccine manufacturer specializing in yellow fever vaccines, to set up a vaccine production plant in Senegal. The project, costing $222 million, is set to be financed via a combination of public, private, and grant funds. This fresh facility will substantially increase IPD’s vaccine production potential, which has been traditionally centered around yellow fever. The plant will initially start with COVID-19 vaccine production and gradually move to other vaccines. The ultimate goal for this facility is to produce as many as 300 million doses yearly for Africa.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19946
Which regions are emerging as leaders in the yf-vax market?
North America was the largest region in the yf-vax market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yf-vax market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Patient Temperature Monitoring Global Market Report 2025
Cold Chain Temperature Monitoring Global Market Report 2025
In-Vitro Transcription Templates Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
